2024 revision of the McDonald diagnostic criteria for MS: Substantial and substantive changes

McDonald WI Compston DA Edan G , et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121–127.

Polman CH Reingold SC Edan G , et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald criteria. Ann Neurol 2005; 58: 840–846.

Polman CH Reingold SC Banwell B , et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69(2): 292–302.

Thompson A Banwell B Barkoff F , et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018; 17(2): 162–173.

Montalban X Lebrun-Frenay C Oh J , et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol 2025; 24(10): 850–865.

Barkhof F Reich DS Oh J , et al. MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosis. Lancet Neurol 2025; 24(10): 866–879.

Saidha S Green A Leocani L , et al. The use of optical coherence tomography and visual evoked potentials in the 2024 McDonald diagnostic criteria for multiple sclerosis. Lancet Neurol 2025; 24: 880–892.

Deisenhammer F Hegen H Arrambide G , et al. Positive cerebrospinal fluid in the 2024 McDonald criteria for multiple sclerosis. eBioMedicine DOI: 10.1016/j.ebiom.2025.105905. https://doi.org/10.1016/j.ebiom.2025.105905

Kuhlmann T Moccia M Coetzee T , et al. Multiple sclerosis progression: Time for a new mechanism-driven framework. Lancet Neurol 2023; 22(1): 78–88.

Tremlett H Munger KL Makhani N . The multiple sclerosis prodrome: Evidence to action. Front Neurol 2022; 12: 761408.